Incremental Prognostic Impact of Peripheral Microvascular Endothelial Dysfunction on the Development of Ischemic Stroke

J Am Heart Assoc. 2020 May 5;9(9):e015703. doi: 10.1161/JAHA.119.015703. Epub 2020 Apr 22.

Abstract

Background Peripheral microvascular endothelial dysfunction (PMED) has been linked to an increased risk of cardiovascular events, but there is a lack of information characterizing the predictive value of PMED for future risk of ischemic stroke (IS). Methods and Results This retrospective observational cohort study enrolled 637 patients who underwent non-invasive microvascular endothelial function assessment using reactive hyperemia peripheral arterial tonometry. Reactive hyperemia peripheral arterial tonometry index ≤2 was defined as PMED. Of 280 patients with PMED, 12 (4.3%) patients developed IS, compared with only 4 (1.1%) of 357 patients without PMED during a median follow-up of 5.3 years. Patients with PMED had lower IS-free survival compared with patients without PMED (log-rank P=0.03). Cox proportional hazard ratio (HR) analyses showed that PMED predicted the incidence of IS, with a HR of 3.43, 95% CI, 1.10-10.63 (P=0.03); adjusted HR of 3.70, 95% CI, 1.18-11.59 (P=0.02) after adjusting for sex, smoking history, and atrial fibrillation; adjusted HR of 3.45, 95% CI, 1.11-10.72 (P=0.03) after adjusting for CHA2DS2-VASc score; adjusted HR of 5.70, 95% CI, 1.40-23.29 (P=0.02) after adjusting for revised Framingham Stroke Risk Score. Reactive hyperemia peripheral arterial tonometry index improved discrimination of risk for IS after adding reactive hyperemia peripheral arterial tonometry index to CHA2DS2-VASc score and revised Framingham Stroke Risk Score. Conclusions PMED was associated with a >3-fold increased risk of IS. These findings underscore the concept of the systemic nature of endothelial dysfunction, which could act as a potential marker to predict future risk of IS.

Keywords: endothelial dysfunction; ischemic stroke; microvascular dysfunction; vascular reactivity.

Publication types

  • Observational Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Comorbidity
  • Disease-Free Survival
  • Endothelium, Vascular / physiopathology*
  • Female
  • Humans
  • Hyperemia / physiopathology
  • Incidence
  • Ischemic Stroke / diagnosis
  • Ischemic Stroke / epidemiology*
  • Ischemic Stroke / physiopathology
  • Male
  • Microcirculation*
  • Middle Aged
  • Minnesota / epidemiology
  • Peripheral Arterial Disease / diagnosis
  • Peripheral Arterial Disease / epidemiology*
  • Peripheral Arterial Disease / physiopathology
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Time Factors